Table 2.
Clinical outcomes for patients undergoing telemedicine surveillance for suspected or confirmed COVID-19
| Characteristic | n (%) |
|---|---|
| Referral origin | |
| Outpatient care | 109 (80.7) |
| L&D triage | 8 (5.9) |
| ED | 4 (3.0) |
| Postdischarge after COVID-19 admission | 10 (7.4) |
| L&D screening | 4 (3.0) |
| Reason for surveillance | |
| Signs and symptoms | 92 (68.1) |
| Exposure | 20 (14.8) |
| Both | 23 (17.0) |
| At least 1 COVID-19 test performed | 68 (50.4) |
| Positive | 22 (16.3) |
| Negative | 44 (32.6) |
| No result | 2 (1.5) |
| Clinical management | |
| Telemedicine only | 116 (85.9) |
| Recommended ambulatory evaluation | 13 (9.6) |
| Recommended urgent evaluation (ED or L&D) | 6 (4.4) |
| Unplanned emergent evaluation | 0 (—) |
| Hospital admission | 9 (6.6) |
| Admission after ambulatory evaluation | 5 (—) |
| Admission after urgent evaluation | 4 (—) |
| Readmission | 1 (0.7) |
COVID-19, coronavirus disease 2019; ED, emergency department; L&D, labor and delivery.
Reforma et al. Multidisciplinary telemedicine model for coronavirus disease 2019 in obstetric patients. AJOG MFM 2020.